
ABOUT CITELINE
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth.
Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more.
FEATURED CONTENT
-
Get a 2022 snapshot of overall trial activity, distribution of trials by disease area, and top industry sponsors/collaborators.
-
Sponsors working to address the dropout rate for Phase 3 clinical trials should review this insight on how to be more mindful of the patient's quality of life and how that can boost retention.
-
One of the biggest challenges in recruiting patients for a clinical study is creating awareness among potential participants. Learn why sponsors must find better ways to get the word out.
-
Delve into in-depth analyses of diseases, players, and geographies involved with Phase 1–3 clinical trials initiated in 2022 across all therapeutic areas covered comprehensively by Trialtrove that influenced the pharmaceutical industry.
-
Get an overview of sponsors' ongoing challenges regarding diversity in clinical trials and the innovative ways they are striving to overcome them.
-
Learn how TrialScope Intelligence centralizes all the regulatory knowledge needed in a user-friendly format, giving sponsors the information they need to compare clinical trial disclosure regulations in seconds.
-
See how this referral network, forged from unique relationships with 100+ traditional and non-traditional recruitment partners, is connecting sponsors with diverse populations.
-
Haley Quinn, Director of Product Success for Citeline Connect, shares her own medical journey and how it both impassions her and impacts her work on a day-to-day basis.
-
Recruiting patients for clinical trials can be tricky. Discover how teams can create more patient-centered clinical trials, which can ultimately benefit both patients and the research community.
-
Tap into a diverse, tokenized real-world dataset covering over 300 million U.S. lives and utilize longitudinal transaction-level patient data and live test/biomarker results.
-
Uncover how real-world data can not only be used for any type of clinical trial, but study sponsors can also use RWD to inform all stages of a study.
-
To date this year, 115 updates to clinical trial disclosure rules have been tracked across global regulatory agencies. See what types of changes have occurred, where they were, and how they are implemented.
-
Take a look at the five top trends shaping the pharmaceutical industry and their effect on patient engagement and recruitment to see if your organization is keeping pace.
-
Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.
-
Get an in-depth analysis of big pharma valuations following the CMS' initial roster of 10 drugs for Medicare negotiations under the Inflation Reduction Act, which included some unexpected developments and products nearing the end of their patent exclusivity.
-
Examine the challenges, potential risks, recommended best practices, and future trends related to anonymizing personal data for Clinical Trials Information System submissions.
-
Patient advocacy groups can play a key role in educating patients about ― and ultimately enrolling them in ― clinical trials. Learn why these groups are trusted sources among community members.
-
The Citeline Connect platform powers a growing network of 100+ vetted organizations ― recruitment partners, advocacy organizations, trial sites and more ― to help sponsors find, educate, engage, and enroll clinical trial participants more quickly and efficiently than ever before.
-
Consider this alternative approach to distributing trial results summaries to participants that takes advantage of commonly used technologies.
-
Discover how Sitetrove’s proprietary Investigator Prioritization tool and Patient Proximity filter enabled this sponsor to zero in on investigators, their types of trials, as well as patient demographics and location.
CONTACT INFORMATION
Citeline
605 Third Ave.
New York, NY 10158
UNITED STATES
Phone: 1 212-600-3530
Contact: Steven Horlock
FEATURED SOLUTIONS
- Accelerating Patient Engagement And Recruitment
- Mastering Multi-Channel, Multi-Vendor Clinical Trial Recruitment
- Educate, Engage, Enroll: Accelerating Patient Recruitment
- Finally, An End-To-End Patient Recruitment Platform
- Connecting The Dots For Patient Recruitment
- How The Sitetrove Diversity Module Can Diversify Studies
- Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios
- Citeline’s Pharmaprojects & Biomedtracker Solution
- TrialScope Intelligence Disclosure Regulatory Tracking
- Widen The Trial Recruitment Funnel, Streamline Engagement, & Enrollment
- Pharmaprojects By Citeline
- Real World Data Solutions
- Helping Sponsors Keep Up With The Latest Clinical Trials Intelligence
- Comprehensive Data And Analytics For Cell, Gene, And RNA-Based Therapies
- TrialScope Disclosure Services Workshops
FEATURED WEBINARS
-
Consider this diverse range of real-world perspectives, complemented by data-driven insights, when looking to enhance the speed, accessibility, and efficiency of clinical trial processes.
-
Listen in as industry leaders discuss how to meet the needs of multiple stakeholders while ensuring operational efficiency, study success, and enterprise scale.
-
See the results of a joint survey with 1nHealth on how compensation is likely to impact participation in clinical trials, followed by a thought-provoking roundtable on this timely topic.
-
In this webinar, discover the trends shaping pharma’s R&D pipeline, with data broken down by therapeutic area, disease, mechanism and target, and drug type.
-
Now that the EU’s Clinical Trials Information System (CTIS) is up and running, disclosure and transparency experts from Sarepta, Boehringer Ingelheim, Bayer and Merck KgaA discuss the ins and outs of registering clinical trials and submitting study information to the portal.
-
Disclosure experts Thomas Wicks and Francine Lane explain the importance of consistency and creating a disclosure template, plain language summaries source documents, and authoring with redaction in mind.
-
In this informative webinar, clinical trial disclosure experts Francine Lane and Thomas Wicks provide a high-level overview of EU CTR/CTIS regulations, show how they differ from the EU CTD directive, share timelines for compliance, and discuss the scope of data sharing.
-
In this presentation delivered at SCOPE 2022, hear how ICON leveraged Study Feasibility to its advantage.
-
Because there are no regulations mandating study diversity, it is up to sponsors to take the lead. In this webinar, panelists discuss how trust, accessibility and technology combine to improve the diversity of clinical trial of participants.
-
When Craig Lipset talks pharma, people listen. The former Head of Clinical Innovation and Venture Partner at Pfizer shares his insights on clinical trial transparency and is joined by Chris Boone of AbbVie in a fireside chat.